Yes, and the differences are bigger than most clinics explain. A testosterone pellet dose for a woman is roughly a tenth of a man’s. The only FDA approved testosterone pellet is licensed for men, so pellets placed in women in the United States are compounded and used off label. And the side effects that matter most in women are androgenic ones such as facial hair, acne and voice change, which cannot be dialed back quickly, because a pellet is not adjustable once it is under the skin.
The dose gap is an order of magnitude
Testopel, the FDA approved testosterone pellet, contains 75 mg per pellet, and its label gives a usual dosage of 150 mg to 450 mg implanted every three to six months for men with testosterone deficiency.
Compounded pellets prescribed to women are far smaller. A 2025 review of testosterone pellets in women reports doses commonly in the range of 50 to 200 mg, with 75 to 100 mg considered closer to physiologic, releasing roughly 0.6 to 0.8 mg per day, close to what the ovaries themselves produce.
Same technology, very different scale. This matters because the margin for error in women is narrow. A dosing step that would be unremarkable in a man can push a woman well above her normal range and keep her there for months.
The regulatory status is not the same either
There is currently no FDA approved testosterone product for women in the United States. Every testosterone pellet placed in a woman here is therefore a compounded preparation used off label.
Compounded drugs are not reviewed by the FDA for safety, effectiveness or manufacturing quality before they reach patients, a point the agency makes plainly in its compounding guidance. In 2020, the National Academies reviewed compounded bioidentical hormone therapy and concluded that the evidence was insufficient to support its widespread clinical use.
Off label prescribing is legal and routine across medicine, so this is not a reason to panic. It is a reason to be skeptical of any clinic that presents pellets for women as an approved, well studied therapy. They are not that.
What pellets actually do to a woman’s blood levels
In postmenopausal women, total testosterone measured by mass spectrometry typically falls around 10 to 55 ng/dL, and women on treatment are meant to stay inside a premenopausal range of roughly 20 to 80 ng/dL.
Pellets frequently overshoot that. The same review describes a study in which mean total testosterone reached about 299 ng/dL roughly four weeks after insertion, and still averaged about 171 ng/dL by the time of reinsertion. Those are several times the intended range, sustained across months.
This is the core of the professional objection. The 2019 Global Consensus Position Statement on testosterone therapy for women, endorsed by the Endocrine Society and the International Menopause Society among others, concluded that the only evidence based indication for testosterone in women is hypoactive sexual desire disorder after menopause, and that formulations should target the premenopausal physiologic range rather than exceed it.
Men are not immune to overshoot. But a man’s therapeutic window is wide, and the consequences of running high are different from the ones women face.
The side effects women report
In observational cohorts of women on pellets, mild androgenic effects were common. One cohort reported facial hair growth in about 86 percent of women, moderate acne in about 11 percent, and transient hoarseness in about 1 percent. A lower dose cohort reported much less, around 5 percent new facial hair and 3 percent acne.
Read those numbers carefully. They come from registries and cohorts that were not randomized or blinded, and some carry acknowledged conflicts of interest. They tell you what tends to happen, not a precise personal risk.
The structural problem is harder than the numbers. A pellet cannot be easily removed once it is in place. The American College of Obstetricians and Gynecologists, in its clinical consensus on compounded bioidentical menopausal hormone therapy, recommends preparations other than pellets for delivering testosterone to women, citing the absence of safety data and the inability to remove the implant. If a level runs too high, the honest answer is usually that you wait.
What the evidence honestly supports
Only one randomized controlled trial has specifically studied testosterone pellets in women, and it dates to 1995. Everything since is observational. Some cohorts report improvements in sexual function, mood, energy and bone density, and some report favorable breast cancer signals, but none of those studies were designed to establish cause, and the reviewers say so directly.
The randomized evidence for testosterone in women sits with transdermal formulations, not pellets. So the fair summary is this: pellets reliably raise testosterone, and some women feel better on them. Whether pellets outperform a cream or gel titrated into the physiologic range has not been shown. Bone protection, cognitive benefit and cardiovascular prevention are not established indications for testosterone in women, whatever the delivery route.
If you want the fuller safety picture, our companion piece on whether hormone pellets are safe goes deeper, and injections versus pellets covers the male side of the comparison.
Red flags that mean call a clinician, not a clinic
- A voice that deepens, or hoarseness that does not resolve
- Clitoral enlargement
- Rapid scalp hair thinning, or fast new coarse facial hair
- Severe or sudden acne
- Any vaginal bleeding after menopause, which needs evaluation on its own terms and should never be dismissed as a hormone side effect
- Redness, pain, drainage, or a pellet working its way back out through the skin
- Pregnancy, trying to conceive, or breastfeeding, in which case testosterone is not appropriate
What careful pellet care looks like
If you and your clinician decide pellets are still the right choice, hold them to the standard any hormone therapy deserves. A documented reason for treatment. Baseline labs including total testosterone by mass spectrometry, plus estradiol, SHBG and a complete blood count. A stated target range. Repeat levels before the next insertion rather than after symptoms appear. And a clinician who will lower the dose or change route when the numbers say so.
At MetaHealth we review symptoms, labs and delivery routes together before anyone commits to a pellet, and we say plainly when a cream or gel is the better starting point. More on our hormone therapy page, in person in Deerfield Beach or by telehealth across Florida.
Medically reviewed by Krishna Borges, MSN, APRN, FNP-C. This article is for general education and is not a substitute for individual medical advice.